A randomized phase II study comparing single agent gemcitabine intravesical therapy versus mitomycin C in patients with intermediate risk superficial bladder cancer
Phase of Trial: Phase II
Latest Information Update: 24 May 2007
At a glance
- Drugs Gemcitabine; Mitomycin
- Indications Bladder cancer
- Focus Therapeutic Use
- 24 May 2007 Status change from in progress to completed.
- 02 Nov 2005 New trial record.